Insulin Aspart and Metoprolol: Drug Interaction Guide

Quick answer: This combination requires caution. Insulin Aspart and Metoprolol can be used together with adjustments and monitoring.

Interaction severity: Moderate — caution required

How Insulin Aspart interacts with Metoprolol

Beta-adrenergic blockade can mask adrenergic warning symptoms of hypoglycaemia and may delay glucose recovery, although beta-1-selective metoprolol has less effect than nonselective beta blockers.

What you should do

Do not routinely withhold indicated beta-blocker therapy, but intensify glucose monitoring and counsel the patient that sweating or neuroglycopenic symptoms may be the main warning signs.

Key facts

Severity

Moderate — caution required

Mechanism

Beta-adrenergic blockade can mask adrenergic warning symptoms of hypoglycaemia and may delay glucose recovery, although ...

Action

Do not routinely withhold indicated beta-blocker therapy, but intensify glucose monitoring and counsel the patient that ...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Insulin Aspart and Metoprolol together?

With caution. Do not routinely withhold indicated beta-blocker therapy, but intensify glucose monitoring and counsel the patient that sweating or neuroglycopenic symptoms may be the main warning signs.

What is the severity of this interaction?

The interaction between Insulin Aspart and Metoprolol is classified as Moderate — caution required. Beta-adrenergic blockade can mask adrenergic warning symptoms of hypoglycaemia and may delay glucose recovery, although beta-1-selective metoprolol has less effect than nonselective beta blockers.

What should I do if I'm prescribed both?

Do not routinely withhold indicated beta-blocker therapy, but intensify glucose monitoring and counsel the patient that sweating or neuroglycopenic symptoms may be the main warning signs. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.